New Year Bumper Sale @ Rs. 1 X
Telmeron CH 40 Mg/12.5 Mg Tablet is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Telmeron CH 40 Mg/12.5 Mg Tablet have also been mentioned below.
The correct dosage of Telmeron CH 40 Mg/12.5 Mg Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Telmeron CH 40 Mg/12.5 Mg Tablet include Dizziness, Nausea or vomiting, Back Pain. While these are the most often observed Telmeron CH 40 Mg/12.5 Mg Tablet side effects, there are can be others also. These have been listed below. Such side effects of Telmeron CH 40 Mg/12.5 Mg Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Telmeron CH 40 Mg/12.5 Mg Tablet has a Mild effect for pregnant women and Mild effect on lactating mothers. Further, the section on Telmeron CH 40 Mg/12.5 Mg Tablet related warnings talks about Telmeron CH 40 Mg/12.5 Mg Tablet's effects on the liver, heart and kidney.
Telmeron CH 40 Mg/12.5 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Telmeron CH 40 Mg/12.5 Mg Tablet in conditions like Angioedema, Hyperkalemia, Drug Allergy. The section on Telmeron CH 40 Mg/12.5 Mg Tablet contraindications lists all such conditions.
Drug reaction of Telmeron CH 40 Mg/12.5 Mg Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Telmeron CH 40 Mg/12.5 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Telmeron CH 40 Mg/12.5 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Telmeron CH 40 Mg/12.5 Mg Tablet is used -
Severe
Mild
Common
Is the use of Telmeron CH 40 Mg/12.5 Mg Tablet safe for pregnant women?
Telmeron Ch has mild to no side effects in pregnant women.
Is the use of Telmeron CH 40 Mg/12.5 Mg Tablet safe during breastfeeding?
Telmeron Ch has been seen to have minimal side effects on breastfeeding women.
What is the effect of Telmeron CH 40 Mg/12.5 Mg Tablet on the Kidneys?
Telmeron Ch rarely affects the kidneys.
What is the effect of Telmeron CH 40 Mg/12.5 Mg Tablet on the Liver?
Telmeron Ch may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Telmeron CH 40 Mg/12.5 Mg Tablet on the Heart?
Telmeron Ch may have mild side effects on the heart. Most people will never see any effect on the heart.
Telmeron CH 40 Mg/12.5 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telmeron CH 40 Mg/12.5 Mg Tablet unless your doctor advises you to do so -
Is this Telmeron CH 40 Mg/12.5 Mg Tablet habit forming or addictive?
No, you will not get addicted to Telmeron CH 40 Mg/12.5 Mg Tablet.
Interaction between Food and Telmeron CH 40 Mg/12.5 Mg Tablet
Eating certain foods may increase the time it takes Telmeron CH 40 Mg/12.5 Mg Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Telmeron CH 40 Mg/12.5 Mg Tablet
Taking alcohol with Telmeron CH 40 Mg/12.5 Mg Tablet can be dangerous.
Telmeron Ch contains telmisartan which is an antihypertensive drug that works by preventing a chemical (angiotensin II) to bind with a receptor. This causes relaxation of blood vessels, it also prevents the synthesis and release of aldosterone (a hormone whose hyperactivity results in high blood pressure). In this way Telmeron Ch decreases the blood pressure.
No, Telmeron Ch doesn't cause a headache. However, if you experience a headache while using Telmeron Ch, please consult your doctor without any delay.
Telmeron Ch is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Telmeron Ch might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Telmeron Ch exactly as prescribed by their doctor.
Telmeron Ch can be taken as long as it is prescribed by your doctor. You must not discontinue taking it even when you start feeling well. In addition, you must not take it more frequently as that can have adverse effects. Follow the recommendations of your doctor completely.
Yes, it is safe to take Telmeron Ch as long as it is prescribed by your doctor. However, in some people, it may cause some side effects like back pain, sinusitis, and diaarhea.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448